Effect of Exceptional Parental Longevity and Lifestyle Factors on Prevalence of Cardiovascular Disease in Offspring.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 29050682)

Published in Am J Cardiol on September 18, 2017

Authors

Sriram Gubbi1, Elianna Schwartz2, Jill Crandall2, Joe Verghese3, Roee Holtzer4, Gil Atzmon5, Rebecca Braunstein2, Nir Barzilai6, Sofiya Milman7

Author Affiliations

1: Department of Medicine, Institute for Aging Research, Albert Einstein College of Medicine, Bronx, New York; Department of Internal Medicine, Jacobi Medical Center, Bronx, New York.
2: Department of Medicine, Institute for Aging Research, Albert Einstein College of Medicine, Bronx, New York.
3: Department of Medicine, Institute for Aging Research, Albert Einstein College of Medicine, Bronx, New York; Department of Neurology, Albert Einstein College of Medicine, Bronx, New York.
4: Department of Neurology, Albert Einstein College of Medicine, Bronx, New York; Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York.
5: Department of Medicine, Institute for Aging Research, Albert Einstein College of Medicine, Bronx, New York; Department of Genetics, Albert Einstein College of Medicine, Bronx, New York; Department of Natural Science, University of Haifa, Haifa, Israel.
6: Department of Medicine, Institute for Aging Research, Albert Einstein College of Medicine, Bronx, New York; Department of Genetics, Albert Einstein College of Medicine, Bronx, New York.
7: Department of Medicine, Institute for Aging Research, Albert Einstein College of Medicine, Bronx, New York. Electronic address: sofiya.milman@einstein.yu.edu.

Articles cited by this

Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 20.98

Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health (1992) 15.38

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA (1998) 8.21

Optimal diets for prevention of coronary heart disease. JAMA (2002) 7.24

Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA (2003) 6.17

A reduced dietary questionnaire: development and validation. Epidemiology (1990) 5.41

European population substructure: clustering of northern and southern populations. PLoS Genet (2006) 5.27

Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc (2001) 3.74

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med (2016) 3.68

Morbidity profiles of centenarians: survivors, delayers, and escapers. J Gerontol A Biol Sci Med Sci (2003) 3.67

Genetic signatures of exceptional longevity in humans. PLoS One (2012) 3.20

Life-long sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci U S A (2002) 2.96

Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. J Am Geriatr Soc (2009) 2.30

Clinical phenotype of families with longevity. J Am Geriatr Soc (2004) 2.03

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia. N Engl J Med (2015) 2.03

Centenarians: the older you get, the healthier you have been. Lancet (1999) 1.92

Lower all-cause, cardiovascular, and cancer mortality in centenarians' offspring. J Am Geriatr Soc (2004) 1.78

Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J Am Geriatr Soc (2005) 1.68

Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States. JAMA (2017) 1.44

Lifestyle factors of people with exceptional longevity. J Am Geriatr Soc (2011) 1.27

Centenarian offspring: start healthier and stay healthier. J Am Geriatr Soc (2008) 1.26

Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity. J Am Geriatr Soc (2016) 0.80

Association of exceptional parental longevity and physical function in aging. Age (Dordr) (2014) 0.79

Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span. Cold Spring Harb Perspect Med (2015) 0.79

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics. Am Heart J (2017) 0.75